TITLE:  Introducing & Using Long-Acting Injectable Buprenorphine in the ED

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Describe the clinical and public health need for long-acting injectable buprenorphine initiation in the ED setting.
• Identify appropriate patient populations for ED-based LAIB treatment, including those with barriers to daily dosing or follow-up.
• Review dosing, timing, and administration protocols for safely initiating LAIB in the emergency department.
• Develop practical strategies for incorporating LAIB into existing ED workflows, including nursing, pharmacy, and discharge coordination.
• Analyze and discuss regulatory, storage, consent, and billing considerations specific to long-acting formulations.
• Create and Implement follow-up pathways that connect ED-treated patients to ongoing addiction care and support services.
• Evaluate outcomes such as patient retention, ED recidivism, and overall quality of OUD care.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.